Cargando…
Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis
Gastric cancer is the second most common cause of cancer-related mortality worldwide. Accurate prediction of disease progression is difficult, and new biomarkers for clinical use are essential. Recently, we reported that the proteasome-associated deubiquitinating enzyme UCHL5/Uch37 is a new prognost...
Autores principales: | Arpalahti, Leena, Laitinen, Alli, Hagström, Jaana, Mustonen, Harri, Kokkola, Arto, Böckelman, Camilla, Haglund, Caj, Holmberg, Carina I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825037/ https://www.ncbi.nlm.nih.gov/pubmed/29474458 http://dx.doi.org/10.1371/journal.pone.0193125 |
Ejemplares similares
-
High PROX1 expression in gastric cancer predicts better survival
por: Laitinen, Alli, et al.
Publicado: (2017) -
Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome
por: Kasurinen, Aaro, et al.
Publicado: (2019) -
Podocalyxin as a Prognostic Marker in Gastric Cancer
por: Laitinen, Alli, et al.
Publicado: (2015) -
High serum MMP-14 predicts worse survival in gastric cancer
por: Kasurinen, Aaro, et al.
Publicado: (2018) -
Podocalyxin is a marker of poor prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)